Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shinji Kanemitsu is active.

Publication


Featured researches published by Shinji Kanemitsu.


Shock | 2001

Ultrafiltration of the priming blood before cardiopulmonary bypass attenuates inflammatory response and improves postoperative clinical course in pediatric patients.

Hideto Shimpo; Akira Shimamoto; Yutaka Sawamura; Kazuya Fujinaga; Shinji Kanemitsu; Koji Onoda; Motoshi Takao; Yoshihide Mitani; Isao Yada

ABSTRACT The priming solution using in cardiopulmonary bypass (CPB) for infants undergoing cardiac surgery includes considerable amounts of stored blood. Our objective was to test the hypothesis that ultrafiltration (UF) of the stored blood before CPB reduces the unfavorable effects of stored blood and the production of inflammatory cytokines. Fifty pediatric patients with congenital heart defects took part in this study. The patients were randomly divided into two groups: the UF (27 pediatric patients who received UF) and control (23 pediatric patients who did not receive UF) groups. UF was performed with a polysulphone ultrafiltrator before CPB. Blood samples were collected immediately before, during, and 1 h after CPB. The levels of cytokines (TNF‐&agr;, IL‐1&bgr;, IL‐8), NH3, and bradykinin were determined. The serum concentrations of NH3 and bradykinin decreased significantly after UF. Compared with the control group, the UF group had significantly lower cytokine production. Water balance in UF group was better than that of control group. The UF group received significantly less inotropic support and shorter duration of ventilator support and ICU stay. We conclude that removal of bradykinin and a decrease in the levels of NH3, potassium, and pH play a significant role in reducing water retention and postoperative lung injury. UF of the blood used to prime the circuit for CPB is a safe and efficient method for use in open heart surgery in small pediatric patients.


The Annals of Thoracic Surgery | 2000

Biocompatibility of silicone-coated oxygenator in cardiopulmonary bypass

Akira Shimamoto; Shinji Kanemitsu; Kazuya Fujinaga; Motoshi Takao; Koji Onoda; Takatsugu Shimono; Kuniyoshi Tanaka; Hideto Shimpo; Isao Yada

BACKGROUND This study was designed to analyze the biocompatibility of silicone-coated oxygenators using inflammatory response as the outcome measure, and to investigate whether the silicone-coated oxygenators perform better in terms of postoperative organ dysfunction. METHODS The 32 patients who underwent cardiopulmonary bypass (CPB) were divided into 3 groups: group A (n = 10), heparin-coated circuit with silicone-coated oxygenator; group B (n = 11), whole heparin-coated circuit; and group C (n = 11), whole untreated circuit. The plasma concentrations of the proinflammatory markers, made of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, interleukin-8), terminal complement complex (C5b-9), and polymorphonuclear elastase (PMN-E), were measured by enzyme-linked immunosorbant assay. RESULTS All proinflammatory markers were significantly lower in groups A and B than in group C, especially C5b-9 and PMN-E concentrations, which were significantly lower in group A than in group B. The alveolar-arterial oxygen gradients (A-aDO2) and the respiratory index were significantly better in group A than in group C. In group B, however, only the A-aDO2 was significantly better than in group C. The duration of intubation and the length of stay in the intensive care unit stay were significantly shorter in groups A and B than in group C. CONCLUSIONS Silicone-coated oxygenators are biocompatible and prevent postoperative organ dysfunction.


Journal of Vascular Surgery | 2011

Molecular diagnosis of nonaneurysmal infectious aortitis

Shinji Kanemitsu; Takatsugu Shimono; Akiko Nakamura; Kiyohito Yamamoto; Hideo Wada; Hideto Shimpo

We report a 79-year-old patient who presented with a fever and abdominal pain. The patient was initially thought to have a retroperitoneal fibrosis or inflammatory abdominal aortitis in a normal-sized caliber aorta. Broad-range polymerase chain reaction (PCR) and DNA sequencing revealed the presence of Enterobacter. We finally diagnosed nonaneurysmal infectious aortitis, and we performed a successful surgical resection. Establishing a diagnosis of aortic infection before formation of an aneurysm is difficult. The molecular diagnostic technique was particularly useful in specifying the microbial species and diagnosis.


The Annals of Thoracic Surgery | 2001

Synchronous primary lung carcinoma and lung metastasis from extrathoracic carcinoma

Shinji Kanemitsu; Motoshi Takao; Akira Shimamoto; Hideto Shimpo; Isao Yada

We present the cases of 2 patients in whom primary lung cancer was found unexpectedly when pulmonary resection was performed for metastatic lung cancer. The possibility of combined primary and metastatic carcinoma should be considered in patients with a diagnosis of multiple pulmonary metastases from extrathoracic tumor.


The Journal of Thoracic and Cardiovascular Surgery | 2003

Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation☆

Shinji Kanemitsu; Masakatsu Nishikawa; Koji Onoda; Takatsugu Shimono; Hideto Shimpo; Akira Yazaki; Kuniyoshi Tanaka; Hiroshi Shiku; Isao Yada

OBJECTIVE Contact between blood and the synthetic surfaces of a cardiopulmonary bypass circuit leads to platelet activation, and resultant platelet dysfunction contributes to postoperative bleeding. We compared the effects of various platelet inhibitors on preservation of platelet function during simulated cardiopulmonary bypass circulation. METHODS Fresh human blood was recirculated in an in vitro cardiopulmonary bypass model circuit. We measured various platelet activation markers including expressions of PAC-1 and P-selectin, annexin V binding, and microparticle formations by means of whole-blood flow cytometry. RESULTS Two types of glycoprotein IIb/IIIa complex antagonists, peptide-mimetic FK633 and abciximab and prostaglandin E(1), significantly prevented platelet loss and the increase in binding of PAC-1, an antibody specific for fibrinogen receptor on activated platelets, during extracorporeal circulation of heparinized blood. These antagonists significantly suppressed but did not abolish P-selectin expression, annexin V binding, and microparticle formation. Anti-von Willebrand factor monoclonal antibody and aurin tricarboxylic acid (an inhibitor of glycoprotein Ib) had no effect on platelet activation during simulated cardiopulmonary bypass circulation. These data suggest that inhibition of fibrinogen binding glycoprotein IIb/IIIa complex is partly effective in attenuating platelet activation in a heparinized cardiopulmonary bypass model circuit. The direct thrombin inhibitor argatroban prevented platelet loss and expression of P-selectin significantly more than did heparin. A combination of FK633 with argatroban as a substitute for heparin further prevented platelet loss and platelet secretion during simulated cardiopulmonary bypass circulation, although the inhibition of microparticle formation was less. CONCLUSION The inhibition of both platelet adhesion and thrombin may be effective to preserve platelet number and function during cardiopulmonary bypass circulation.


International Journal of Cardiology | 2015

Recurrent inflammatory aortic aneurysms in chronic mucocutaneous candidiasis with a gain-of-function STAT1 mutation

Muneyoshi Tanimura; Kaoru Dohi; Masahiro Hirayama; Yuichi Sato; Emiyo Sugiura; Hiroshi Nakajima; Shinji Kanemitsu; Hidemi Toyoda; Norikazu Yamada; Masahiro Masuya; Kyoko Imanaka-Yoshida; Hideto Shimpo; Eiichi Azuma; Masaaki Ito

a Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan b Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan c Department of Thoracic and Cardiovascular Surgery, Mie University Graduate School of Medicine, Tsu, Japan d Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan e Department of Pathology and Matrix Biology, Mie University Graduate School of Medicine, Tsu, Japan f Department of Cell Transplantation, Mie University Graduate School of Medicine, Tsu, Japan g Mie University Research Center for Matrix Biology, Tsu, Japan


Asian Cardiovascular and Thoracic Annals | 2014

A case of a large cardiac lipoma with coronary artery disease.

Shinji Kanemitsu; Koji Hirano; Takatsugu Shimono; Hideto Shimpo

Cardiac lipomas are extremely rare benign tumors. They usually remain asymptomatic and are detected incidentally. We report an unusual case of a 60-year-old man who presented with a large epicardial lipoma found unexpectedly during coronary artery examinations. Coronary angiography revealed advanced 3-vessel coronary artery disease. We successfully performed simultaneous curative surgery for the large cardiac lipoma and coronary artery bypass grafting. Histopathology confirmed the diagnosis of lipoma; it weighed 450 g and had a stalk connected to the left atrium.


Interactive Cardiovascular and Thoracic Surgery | 2007

Surgical removal of a left ventricular thrombus associated with cardiac sarcoidosis

Shinji Kanemitsu; Yoichiro Miyake; Manabu Okabe

We report successful surgical management of a 31-year-old man with a left ventricular thrombus following heart failure due to cardiac sarcoidosis. Preoperative echocardiography showed diffuse hypokinesis and a mobile ball-like thrombus in the left ventricle. Computed tomography revealed a left ventricular tumor and bilateral hilar lymphadenopathy, while MRI of the brain showed small infarctions in the occipital lobe. Postoperative pathologic examination of a specimen from the left ventricular free wall and a mediastinal lymph node revealed non-caseating granulomas consistent with cardiac sarcoidosis. The patient was referred to a cardiologist for further treatment with prednisolone. This is a rare case of surgical removal of a left ventricular ball-like thrombus in a patient with cardiac sarcoidosis.


Echocardiography-a Journal of Cardiovascular Ultrasound and Allied Techniques | 2016

Calcified amorphous tumor of the heart in a hemodialysis patient

Tetsushiro Takeuchi; Kaoru Dohi; Yuichi Sato; Shinji Kanemitsu; M T Saki Sugiura; Katsunori Uchida; Norikazu Yamada; Misao Takeuchi; Taizo Shiraishi; Hideto Shimpo; Masaaki Ito

We report a case of calcified amorphous tumor (CAT) of the heart in a 60‐year‐old Japanese man on hemodialysis. Because the masses in the mitral annulus developed during two‐year echocardiographic follow‐up, he underwent surgical resection with mitral valve replacement. Histological examination showed that the tumor contained multiple calcified nodules, which confirmed the diagnosis of CAT. This case report reinforces the need to deeply and periodically investigate for cardiac involvement of CAT in all patients on hemodialysis.


Annals of Vascular Diseases | 2011

Improve Morbidity and Mortality in Coronary Artery Bypass Graft Surgery for Severe Atherosclerosis

Shinji Kanemitsu; Sawaka Tanabe; Kensuke Ohue; Hiroyuki Miyagawa; Yoichiro Miyake; Manabu Okabe

OBJECTIVES Atherosclerosis has been identified as a risk factor for both morbidity and mortality in patients undergoing coronary artery bypass grafting (CABG). To investigate outcomes following CABG for severe atherosclerosis, and to determine whether different surgical techniques can reduce the risk of neurologic events in these patients. METHODS We studied 225 consecutive patients who underwent elective isolated CABG. Routine preoperative and intraoperative examinations identified patients with severe atherosclerosis. We compared the outcomes between patients with (group A; 42 ceses) and those without (group N; 183 cases) severe atherosclerosis. RESULTS 36 patients (85.7%) in group A and 176 (96.2%) in group N underwent off-pump coronary artery bypass (OPCAB); 6 (14.3%) in group A and 7 (3.8%) in group N underwent on-pump beating CABG. Three patients in group A suffered deep sternal infection (7.1%), and one suffered stroke (2.4%) compared with none in group N. No cerebral infarction or neurologic events occurred in patients who underwent OPCAB (n = 212, 94.2%). CONCLUSIONS Prevalence of complications was significantly greater among patients with severe atherosclerotic disease who underwent OPCAB than in those without atherosclerotic disease. Careful selection of surgical strategies can prevent perioperative stroke and reduce mortality.

Collaboration


Dive into the Shinji Kanemitsu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hitoshi Suzuki

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge